Febrile neutropenia (FN) is a common complication of chemotherapy in oncological children
and one of the most important causes of morbidity and mortality in these patients. The early …

Routinely measurable biomarkers as predictors for adverse outcomes in febrile neutropenia
could improve management through risk stratification. This systematic review assesses the …

BACKGROUND Hospitalization for febrile neutropenia (FN) in cancer patients is associated
with considerable morbidity, mortality, and cost. The study was undertaken to better define …

Background: The optimal choice of initial antibiotic therapy for patients with high-risk febrile
neutropenia (FN) in children is unclear and varies by the institution on the basis of local …

A retrospective analysis was performed on febrile neutropenic episodes in patients with
acute lymphoblastic leukemia (ALL) from 1992 to 2002. There were 222 febrile neutropenic …

Methods: Pediatric patients with cancer presenting with FN induced by nonmyeloablative
chemotherapy were observed in a prospective multicenter study. A score predicting the risk …

Background Little is known about emergency department (ED) use among pediatric patients
with cancer. We explored reasons prompting ED visits and factors associated with hospital …

Background: Severe sepsis is not clinically apparent during the first 24 hours of
hospitalization in most children with cancer and febrile neutropenia (FN), delaying targeted …

Objectives To study the trend of Clostridium difficile infection (CDI) and risk factors for
hospital acquired CDI (HA-CDI) among children with cancer. Study design We analyzed 33 …

Purpose With the increasing emergence of multiresistant pathogens, better understanding of
these infections is necessary. The aim of the present study was to evaluate the risk factors …